ENTRY       D10352                      Drug
NAME        Dusigitumab (USAN/INN)
FORMULA     C6372H9824N1700O2016S54
EXACT_MASS  144142.3386
MOL_WEIGHT  144231.8734
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYDINWVRQA TGQGLEWMGW MNPNSGNTGY
            AQKFQGRVTM TRNTSISTAY MELSSLRSED TAVYYCARDP YYYYYGMDVW GQGTTVTVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSNFGTQT YTCNVDHKPS NTKVDKTVER KCCVECPPCP APPVAGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTFR
            VVSVLTVVHQ DWLNGKEYKC KVSNKGLPAP IEKTISKTKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPMLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            QSVLTQPPSV SAAPGQKVTI SCSGSSSNIE NNHVSWYQQL PGTAPKLLIY DNNKRPSGIP
            DRFSGSKSGT SATLGITGLQ TGDEADYYCE TWDTSLSAGR VFGGGTKLTV LGQPKAAPSV
            TLFPPSSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS
            SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTECS
            (Disulfide bridge: H22-H96, H134-L216, H147-H203, H222-H'222, H223-H'223, H226-H'226, H229-H'229, H260-H320, H366-H424, H'22-H'96, H'134-L'216, H'147-H'203, H'260-H'320, H'366-H'424, L22-L89, L139-L198, L'22-L'89, L'139-L'198)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-insulin-like growth factor 2 antibody
  TYPE      Monoclonal antibody
TARGET      IGF2 [HSA:3481] [KO:K13769]
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               InsR family
                IGF2
                 D10352  Dusigitumab (USAN/INN)
DBLINKS     CAS: 1204390-13-5
            PubChem: 172232445
///
